These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 18286534)

  • 1. Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful?
    de Mascarel I; MacGrogan G; Debled M; Brouste V; Mauriac L
    Cancer; 2008 Apr; 112(8):1672-8. PubMed ID: 18286534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.
    Pugliese MS; Beatty JD; Tickman RJ; Allison KH; Atwood MK; Szymonifka J; Arthurs ZM; Huynh PP; Dawson JH
    Ann Surg Oncol; 2009 Jan; 16(1):113-20. PubMed ID: 18949520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological significance of occult micrometastases in histologically negative axillary lymph nodes in breast cancer patients using the recent American Joint Committee on Cancer breast cancer staging system.
    Kahn HJ; Hanna WM; Chapman JA; Trudeau ME; Lickley HL; Mobbs BG; Murray D; Pritchard KI; Sawka CA; McCready DR; Marks A
    Breast J; 2006; 12(4):294-301. PubMed ID: 16848838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
    Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
    Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate classification of sentinel lymph node metastases in patients with lobular breast carcinoma.
    Apple SK; Moatamed NA; Finck RH; Sullivan PS
    Breast; 2010 Oct; 19(5):360-4. PubMed ID: 20347308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients.
    Fukagawa T; Sasako M; Shimoda T; Sano T; Katai H; Saka M; Mann GB; Karpeh M; Coit DG; Brennan MF
    Ann Surg Oncol; 2009 Mar; 16(3):609-13. PubMed ID: 19137375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of micrometastases in the sentinel node of patients with invasive breast cancer.
    Hansen NM; Grube B; Ye X; Turner RR; Brenner RJ; Sim MS; Giuliano AE
    J Clin Oncol; 2009 Oct; 27(28):4679-84. PubMed ID: 19720928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
    Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
    Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of axillary lymph-node micrometastases in breast cancer patients.
    Kuijt GP; Voogd AC; van de Poll-Franse LV; Scheijmans LJ; van Beek MW; Roumen RM
    Eur J Surg Oncol; 2005 Jun; 31(5):500-5. PubMed ID: 15922886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nodal-stage classification in invasive lobular breast carcinoma: influence of different interpretations of the pTNM classification.
    van Deurzen CH; Cserni G; Bianchi S; Vezzosi V; Arisio R; Wesseling J; Asslaber M; Foschini MP; Sapino A; Castellano I; Callagy G; Faverly D; Martin-Martinez MD; Quinn C; Amendoeira I; Kulka J; Reiner-Concin A; Cordoba A; Seldenrijk CA; van Diest PJ
    J Clin Oncol; 2010 Feb; 28(6):999-1004. PubMed ID: 20085942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary lymph node nanometastases are prognostic factors for disease-free survival and metastatic relapse in breast cancer patients.
    Querzoli P; Pedriali M; Rinaldi R; Lombardi AR; Biganzoli E; Boracchi P; Ferretti S; Frasson C; Zanella C; Ghisellini S; Ambrogi F; Antolini L; Piantelli M; Iacobelli S; Marubini E; Alberti S; Nenci I
    Clin Cancer Res; 2006 Nov; 12(22):6696-701. PubMed ID: 17121888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic characteristics of the primary tumor in breast cancer patients with isolated tumor cells of the sentinel node.
    Hulvat M; Rajan P; Rajan E; Sarker S; Schermer C; Aranha G; Yao K
    Surgery; 2008 Oct; 144(4):518-24; discussion 524. PubMed ID: 18847634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis.
    Jinno H; Sakata M; Asaga S; Wada M; Shimada T; Kitagawa Y; Suzuki T; Nakahara T; Kitamura N; Kubo A; Mukai M; Ikeda T; Kitajima M
    Breast J; 2008; 14(6):551-5. PubMed ID: 19000054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes.
    Andersson Y; Frisell J; Sylvan M; de Boniface J; Bergkvist L
    J Clin Oncol; 2010 Jun; 28(17):2868-73. PubMed ID: 20458033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of fine-needle aspiration cytology of axillary lymph nodes in breast cancer patients: a study of 115 cases with cytologic-histologic correlation.
    Alkuwari E; Auger M
    Cancer; 2008 Apr; 114(2):89-93. PubMed ID: 18286535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance.
    Rena O; Carsana L; Cristina S; Papalia E; Massera F; Errico L; Bozzola C; Casadio C
    Eur J Cardiothorac Surg; 2007 Dec; 32(6):863-7. PubMed ID: 17936004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells.
    Cserni G; Bianchi S; Boecker W; Decker T; Lacerda M; Rank F; Wells CA;
    Cancer; 2005 Jan; 103(2):358-67. PubMed ID: 15593354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.